Podcasts about ebola virus

"Als relativ schnell dann mit Sicherheit klar war, dass es kein chimäres Ebola-Virus war, sondern „nur“ SARS-CoV-2, musste ... mit aller Macht die Zoonose-Theorie zementiert werden, auch um die bereits laufenden und zukünftigen Gain-of-Function-Forschungen „zu schützen“!" Autor @p3likaan Artikel und Podcast: https://blog.bastian-barucker.de/corona-das-virus-hinter-dem-virus/

TWiV reviews liver damage caused by over use of vitamin A in Texas, vitamin A does not change clinical course of measles in high income country, NIH cuts COVID-19 research, US ends vaccine funds for poor countries, anti-vaxxer hired to study vaccines and autism, new DURC policy, Jamaican fruit bat competence for filoviruses, and human outbreaks of Oropouche virus reassortant in Brazil. Hosts: Vincent Racaniello, Alan Dove, Kathy Spindler, and Brianne Barker Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode Support science education at MicrobeTV ASV 2025 Vitamin A liver disease in Texas (NY Times) Vitamin A doesn't help measles in high-income countries (Pediat Inf Dis) NIH cancels COVID grants (Science) US ends vaccine funds for poor countries (NY Times) Anti-vaxxer to study vaccines and autism (Sci Based Med) DURC rules revised (USG and NIH guidance) Filoviruses and Jamaican fruit bats (Nat Comm) Oropouche outbreaks in Brazil (Nat Med) Woolly mice (NPR) Letters read on TWiV 1205 Timestamps by Jolene Ramsey. Thanks! Weekly Picks Brianne – Math of March Madness Brackets Kathy – Wood frogsicles #1 and #2 Alan – Rare glimpse of baby polar bears emerging from dens Vincent – Hikaru Utada Would Rather Play CERN Than Coachella Intro music is by Ronald Jenkees Send your virology questions and comments to twiv@microbe.tv Content in this podcast should not be construed as medical advice.

What is going on with eggs in the U.S.? Is there a new strain of bird flu? How do you treat TB? How is TB transmitted? What is the most recent Ebola outbreak? Today's episode covers tuberculosis cases in the U.S., the outbreak of TB in Kansas City, and the emergence of a new bird flu strain H5N9. AMA's Vice President of Science, Medicine and Public Health, Andrea Garcia, JD, MPH, also breaks down the ongoing Ebola situation in Uganda. She highlights the implications of these health threats, outlines the importance of infectious disease monitoring, virus tracking, and timely public health response strategies. American Medical Association CXO Todd Unger hosts.

Further Reading: https://doi.org/10.1126/sciadv.adr6140

In Ruanda ist es zu einem Ausbruch des tödlichen Marburg-Fiebers gekommen. Es handelt sich um eine Zoonose, sagt Epidemiologin Christina Frank. Die Ausbrüche seien viel kleiner als beim Ebola-Virus, dennoch müssten Infektionsketten gestoppt werden. Reuning, Arndt www.deutschlandfunk.de, Forschung aktuell

A decade ago, the world's eyes were focused nervously on West Africa when Ebola ravaged the region. It left 11,000 people dead in its wake. Now the epidemic is over, does the threat of its return loom and what lessons did the world learn? Arrival of vaccines are a game changer – but new strains can still pose a challenge. The BBC's Africa Correspondent Anne Soy tells Mark Lowen what horrors she saw on the ground when the region was struck. And Naomi Grimley, from the Tony Blair Institute for Global Change and former Global Health Correspondent at the BBC, shares what the world learnt from the largest Ebola epidemic in history.The Global Story brings you trusted insights from BBC journalists worldwide. We're keen to hear from you, wherever you are in the world. We want your ideas, stories and experiences to help us understand and tell The Global Story. Email us at theglobalstory@bbc.com You can also message us or leave a voice note via WhatsApp on +44 330 123 9480. #TheGlobalStory.The Global Story is part of the BBC News Podcasts family. The team that makes The Global Story also makes several other podcasts, such as Americast and Ukrainecast, which cover US news and the war in Ukraine. If you enjoy The Global Story, then we think that you will enjoy some of our other podcasts too. To find them, simply search on your favourite podcast app.This episode was made by Richard Moran and Rachel Hagan. The technical producers were Frank McWeeny and Matt Hewitt. The assistant editor is Sergi Forcada Freixas and the senior news editor is Sam Bonham. Additional reporting by Caroline Loyer.

The 2014 Ebola outbreak devastated West Africa, killing more than 11,000 people over a two year period. One country that suffered was Sierra Leone.The disease started in Guinea, but quickly spread to neighbouring countries. Before May 2014, there had never been an outbreak of Ebola in Sierra Leone. By autumn that year, burial teams were struggling to keep up with the number of corpses that needed burying. Dan Hardoon speaks to Yusuf Kabba, an Ebola survivor from Sierra Leone.(Photo: Headstones in the Waterloo Ebola Graveyard, Sierra Leone. Credit: HUGH KINSELLA CUNNINGHAM/AFP via Getty Images)

On episode #51 of the Infectious Disease Puscast, Daniel and Sara review the infectious disease literature for the weeks of 3/13 – 3/27/24. Hosts: Daniel Griffin and Sara Dong Subscribe (free): Apple Podcasts, RSS, email Become a patron of Puscast! Links for this episode Viral The oral antiviral obeldesivir protects NHPs against Sudan ebolavirus (Science) Monoclonal antibody therapy to treat Ebola virus disease (Curr Opinion Vir) Opinion of anti-Sudan ebolavirus antiviral therapy (Science) Management of norovirus in solid organ and hematopoietic stem cell transplants (Transplant ID) Bacterial Bacteremia from urinary source in hospitalized adults with asymptomatic bacteriuria?(JAMA) UTI research reference standards (Lancet Infectious Diseases) Aspiration pneumonia (CHEST) Household transmission of Strep A (JID) Antimicrobial dosing recommendations for obese patients (Antimicrobial Agents and Chemotherapy) Syphilis testing (MMWR) Predictors of morality from streptococcal bacteremia (CID) Fungal Invasive candidiasis (Nat Rev Disease Primer) Climate change and natural disasters impact on fungal infections (Lancet Microbe) Parasitic Nasal flushing and Acanthamoeba infection (Emerging Infectious Diseases) Miscellaneous Vaccination guidelines for adults with cancer (Journal of Clinical Oncology) Do multiplexed molecular diagnostic tools impact treatment for children with acute gastroenteritis? (CID) Music is by Ronald Jenkees

In Guinea bricht 2014 das Ebolafieber aus. Die Epidemie verbreitet sich über mehrere westafrikanische Länder und gilt als größte seit Entdeckung des Ebolavirus 1976. Von Martina Meißner.

In this episode, we review the high-yield topic of ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Ebola Virus⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠from the Infectious Disease section. Follow ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Medbullets⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ on social media: Facebook: www.facebook.com/medbullets Instagram: www.instagram.com/medbulletsofficial Twitter: www.twitter.com/medbullets Linkedin: https://www.linkedin.com/company/medbullets

Sarah Taylor, CCE sits down with Stephaine Filo, ACE to talk all things editing including her work on A BLACK LADY SKETCH SHOW, DAHMER – MONSTER: THE JEFFREY DAHMER STORY and WE GROWN NOW.  Stephanie Filo, ACE, is a 4-time Emmy winner, 7-time Emmy nominee, Peabody and ACE Eddie award winner who is celebrated for her work across film and television. Most recently, Stephanie made history as the first Picture Editor to be nominated for three editing Emmys in the same year across three different shows. Nominated for her work on Netflix's Dahmer - Monster: The Jeffrey Dahmer Story, created by Ryan Murphy; Hulu's History of the World Part II, a sequel to Mel Brooks' iconic original film; and Robin Thede's groundbreaking HBO series A Black Lady Sketch Show, Stephanie's nominations also make her the first Black editor to be nominated 3 times for Picture Editing in a single year. Stephanie has also been a part of other prior history-making Emmy wins as well. In 2020, for the news documentary Separated, she and Nzinga Blake became the first Sierra Leonean women to win an Emmy award. In 2021 she was awarded for Outstanding Picture Editing for Variety Programming, making herself and her team at the time the first all Women of Color editing team to win an Emmy. Just last year in 2022,  Stephanie was awarded for her work once again, making herself and her colleagues the first all-Black editing team to win an Emmy, as well as the first all-Black editing team to win an ACE Eddie award. Aside from editing television and film, Stephanie spends much of her spare time producing and editing social action campaigns and documentaries, primarily focused on the rights of women and girls worldwide. Some of her notable campaigns include her work with the United Nations, International Labour Organization, and the Obama White House Task Force's It's On Us campaign to combat campus sexual assault. Stephanie's charitable work has been featured in Forbes Magazine, Entertainment Tonight, Telegraph UK, Yahoo, Al Jazeera, XWhy Magazine, and various others. Her work on the news documentary series Mental State earned her a news Emmy nomination for the episode "Aging Out" about youth aging out of the American foster care system. Stephanie also earned an Emmy win for her editing on the Mental State episode "Separated" which covered ICE deportations. Stephanie serves on the board for Girls Empowerment Sierra Leone, a social impact and feminist-based organization for Sierra Leonean girls aged 11-16. She is also one of the co-founders of End Ebola Now, an organization created in 2014 to spread accurate information and awareness about the Ebola Virus and its impact through artistic community activism. Stephanie is based in Los Angeles, CA and Sierra Leone, West Africa.  

Dr. Mireille Kamariza is an Assistant Professor in the Department of Bioengineering at UCLA and co-founder and CEO of OliLux Biosciences, a company dedicated to providing low- cost, portable and reliable diagnostic devices in low-resource settings. She is a chemical biologist with expertise building diagnostics tools against infectious organisms. With a background in chemical biology and infectious disease research, she researches new tools to selectively probe molecular activity of live cells, in real-time, with versatile applications in research and medicine. She was previously a Junior Fellow at the Harvard Society of Fellows working with Prof. Pardis Sabeti at the Broad Institute of Harvard and MIT. There, she worked on developing CRISPR-Cas13 assays to detect bloodborne viruses such as Ebolavirus, Lassa virus, Yellow Fever virus, and many others.  Prior to her appointment at Harvard, she completed her doctoral studies in Biology at Stanford University where she developed a new diagnostic technology for the rapid and simple detection of tuberculosis at the point-of-care. This project was awarded a Bill & Melinda Gates Foundation grant to test their diagnostic devices in places with high levels of disease. In addition, her work was translated into what is now OliLux Biosciences.  Dr. Kamariza has received numerous awards, including being named as one of Chemical & Engineering News's Talented 12 in 2020 and Endpt's 20 under 40 in 2023. In December 2022, Nature Medicine named Dr. Kamariza as one of 11 early-career researchers to watch.  --- Support this podcast: https://podcasters.spotify.com/pod/show/theia-hc/support

In this episode, we review the high-yield topic of⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Ebola Virus ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠from the Microbiology section. Follow ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Medbullets⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ on social media: Facebook: www.facebook.com/medbullets Instagram: www.instagram.com/medbulletsofficial Twitter: www.twitter.com/medbullets --- Send in a voice message: https://podcasters.spotify.com/pod/show/medbulletsstep1/message

In this episode, Sujani sits down with Dr. Asad Naveed to talk about his work with the Ebola outbreak in Sierra Leone, using social media as a platform for health education and mentorship, and providing guidance for those getting started in public health research.You'll LearnAsad's on the ground work with management and prevention of Ebola in Sierra Leone and how he first became involved in community healthHow Asad's field work led to a career in research and what his goals were when returning to schoolPerspective and making changes in global health systemsSocial media and the responsibilities that public facing figures and users haveTips on getting started and climbing up for those interested in public health research and social entrepreneurshipToday's GuestResourcesConnect with Asad on LinkedIn Read and subscribe to Asad's guides and newsletter Read the article about Ebola Virus in Children in Sierra Leone Listen to the previous episode with Jennifer MontiPurchase the book, The Fortune at the Bottom of the Pyramid Support the showJoin The Public Health Career Club: the #1 hangout spot and community dedicated to building and growing your dream public health career.

The first podcast interview experience - the birth of Secrets of Survival (S.O.S.) - Where It All Began Interview about the beginning stages of the novel Coronavirus 2019 with Infectious Disease specialist - Dr. Moorjani Discussion about the Ebola virus outbreak in 2014, Tuberculosis and HIV in the prison setting Originally recorded on February 23, 2020. Originally published on February 25, 2020 Remastered and published on October 22, 2023 as part of the Historical Medicine Series

On this episode of TWiV we discuss unusual properties of monoclonal antibodies: one that that binds the receptor attachment site and blocks infection with all three poliovirus serotypes, and others that inhibit Ebolavirus spread from cell to cell. Hosts: Vincent Racaniello, Dickson Despommier, Alan Dove, Rich Condit, and Angela Mingarelli Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode MicrobeTV Discord Server MicrobeTV store at Cafepress Global Scholar Travel Awards (ASV) Research assistant position in Rosenfeld Lab CBER/FDA (pdf) Monoclonal antibody neutralizes all three poliovirus serotypes (Nat Comm) Blocking Ebolavirus intercellular spread (Cell Rep) Letters read on TWiV 1059 Timestamps by Jolene. Thanks! Weekly Picks Dickson – Climate Science Angela – Spider Ballooning (Wikipedia) Kathy – Richard Harris Art Collection Rich – “The Murderbot Diaries” by Martha Wells Alan – Old Gods of Appalachia Vincent – Poetry Foundation Intro music is by Ronald Jenkees Send your virology questions and comments to twiv@microbe.tv

Olivier Pernet, PhD is an assistant professor of research pediatrics at Keck School of Medicine of USC. He is a virologist with over 15 years of research experience in the field of emerging zoonotic viruses, with a special attention on bat related diseases such as Nipah Virus, Ebola Virus, SARS-CoV-1, and SARS-CoV-2. Pernet's work focuses on host-virus interactions and how to use them for biomedical applications like outbreak preparedness, surveillance, high-throughput serology, drug discovery, and gene therapy.Learn more about this episode and others at pphs.usc.edu/podcastStay in the loop - subscribe to the Preventive Dose newsletter for monthly news straight to your inbox.Follow us on social - find us at @uscpphs Instagram TikTok Facebook LinkedIn X YouTube

Check out our free downloads at nascentmc.com: Implementing AMA Style – 8 Things to Get Right in Your Next Project Needs Assessments – 7 Essentials for Getting Funded Working With Your Medical Writer – 8 Ways to Get the Most out of Them See the full write ups for today's episodes at nascentmc.com/podcast In this week's New FDA Approval's podcast episode, Dr. Emma Hitt Nichols discusses the latest FDA approvals from July 31, 2023 – August  4, 2023.  Please check back every Monday morning so that you can stay up to date.  Here are the highlights: ·      The FDA has approved Zurzuvae, the first oral medication for postpartum depression, showing significant improvement in patient symptoms compared to placebo groups. ·      Jemperli, a PD-1 inhibitor, has been approved by the FDA for use with chemotherapy in adult patients with primary advanced or recurrent endometrial cancer with specific mutations. The drug is already approved for use as a single agent in similar cases and is now indicated for use in the first-line setting, with discussions for a broader indication underway with the FDA. ·      The FDA has approved the oral drug Lonsurf, in combination with bevacizumab, for the treatment of adult patients with metastatic colorectal cancer previously treated with specific chemotherapy and targetd therapies. Lonsurf, initially approved as a single agent in 2015, is also approved for advanced metastatic gastric or gastroesophageal junction adenocarcinoma. ·      The FDA has approved an expanded indication for Ervebo, a vaccine now indicated for the prevention of disease caused by Zaire ebolavirus for individuals aged 12 months and older.  Did you know, you can access our nascentmc.com/podcast page and search the notes from this podcast! So for example, if you search a term like "diabetes" it will bring up all the diabetes related therapeutic agents approved since the first episode on May 15 of this year. We're also including the prescribing information with each summary too. Check it out at nascentmc.com/podcast. Intro and outro music Garden Of Love by Pk jazz Collective  

Have you ever been surprised to discover that something you thought you knew, like a milkweed or a bumblebee, actually encompasses a vast array of distinct species? Well, today we're diving into a world that's equally diverse and captivating: viruses. They may not be as readily observable as plants and animals, but they're an essential part of our natural world.Joining us today is Dr. Robert David Siegel, a renowned professor of microbiology and immunology at Stanford University. With his extensive expertise in virology, Dr. Siegel sheds light on how viruses fit into the broader ecological landscape. We'll explore their types, diversity, and the intriguing ways they infect their hosts and evolve.Ever wondered why some viruses have the ability to infect multiple species or make astonishing jumps from one species to another? We'll delve into this topic, with a focus on well-known examples like influenza and coronaviruses.And let's not forget our own immune system, the incredible shield protecting us from viral invaders. Dr. Siegel takes us on a journey through the basics of our immune response, including insights into the innate and adaptive systems. And did you know that the reaction we get from poison oak and poison ivy is actually an immune response? If you think you are immune to these plants, I suggest you listen.And of course, we can't conclude our discussion without addressing the promises and myths surrounding mRNA vaccines—a vital aspect of virus control.But that's not all! Dr. Siegel, a nature lover and accomplished photographer, shares his tales of chasing and photographing every order of birds in the world. Prepare to be inspired by his remarkable nature endeavors, which he graciously recounts during the final part of our conversation.Get ready to embark on an enlightening and awe-inspiring journey into the world of viruses, their ecological significance, and the wonders of our immune system.FULL SHOW NOTESLINKSWebsitesiNaturalistViralZone WebsiteBooks and Other ThingsNote: links to books are affiliate linksAn Immense World - by Ed YongBreathless: The Scientific Race to Defeat a Deadly Virus - by David QuammanDarwin: The Origin of Species | The Voyage of the BeagleThe Demon in the Freezer: A True Story - by Richard PrestonThe Hot Zone: The Terrifying True Story of the Origins of the Ebola Virus - by Richard PrestonMicrobe Hunters: The Story of the Microscopic Discoveries that Changed the World - by Paul de KruifSome of Dr. Siegel's nature photography and writing in Punch MagazineMusic used for this media project:Music: Spellbound by Brian Holtz MusicFree download: https://filmmusic.io/song/9616-spellboundLicense (CC BY 4.0): https://filmmusic.io/standard-licenseArtist website: https://brianholtzmusic.com Support the show

Are you an indoor kid or an outdoor kid? Are parents living with unnecessary fear for their children? What is the opposite of straight edge and how did it get started? Kyle and Jheisson answer these questions and more as they hike their way across Wikipedia from the Washington D.C. punk scene of the 1980's to present day studies that say kids aren't spending enough time outside. Finally they wrap things up with a shallow dive into some lighthearted topics like the Ebola Virus and Anthrax.Watch full length videos on the Wiki U Youtube page and short form content on TikTok and Instagram @wikiuniversity

Matthew Stein joined us and we had a great time. Are you prepared in case some kind of disaster strikes? Kate and I aren’t as prepared as we want to be and after listening to Matthew talk about everything we’re going to start getting more prepared. For those that don’t know he’s the author of […]

On episode #21 of the Infectious Disease Puscast, Daniel and Sara review the infectious disease literature for the previous two weeks, 1/18/23 – 2/1/23. Hosts: Daniel Griffin and Sara Dong Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of Puscast! Links for this episode The impact of cold temperature in the pattern of influenza virus infection (OFID) Janssen to discontinue Phase 3 Mosaico HIV vaccine clinical trial (JNJ) Randomized trial of vaccines for Zaire Ebola virus disease (NEJM) PD-1 blockade and lenalidomide combination therapy for Epstein-Barr virus infection (CMI) Outcomes of Daptomycin plus Ceftaroline vs alternative therapy for persistent MRSA bacteremia (IJAA) Detection of a novel strain of multidrug-non-susceptible Neisseria gonorrhoeae (The Lancet) Impact of a device to reduce blood culture contamination and false-positive central-line bloodstream infections (ICHE) Addition of anaerobic coverage for treatment of biliary tract infections (JAC) High dose Cefepime vs Carbapenems for bacteremia caused by Enterobacterales(OFID) Assessing the diagnostic performance of IGRAs for Mycobacterium tuberculosis (CID) Infective endocarditis after transcatheter aortic valve replacement (JACC) Discordant clinical and microbiological outcomes are associated with late clinical relapse in clinical trials for complicated UTIs (CID) Real-world use of bezlotoxumab and fecal microbiota transplantation for the treatment of Cdiff (OFID) Blastomycosis in New England (OFID) Management of invasive candidiasis in hematopoietic cell transplant recipients (TCT) Short course of Antifungal therapy in patients with uncomplicated Candida Bloodstream infection (OFID) Parasites and childhood stunting (Cell) Comparing complication rates of midline catheter vs. PICC line (OFID) Novel prion strain as the cause of chronic wasting disease in a moose (EID) Agreement of respiratory viruses' detection between nasopharyngeal swab and bronchoalveolar lavage in adults with pneumonia (CMI) Music is by Ronald Jenkees

Dr. Steven Hatfill is a virologist and bioweapons expert. In 2001, he was falsely accused of the Amerithrax anthrax attacks, before proving his innocence and winning a $5.8 million settlement from the DOJ. In 2020, he advised the White House on its response to the COVID-19 pandemic. ••「 LINKS FROM EPISODE: https://drdrew.com/1182023  」••  Dr. Hatfill is the coauthor of 2019's "Three Seconds Until Midnight" which describes "major faults and assumptions in US planning... and several major steps that must be taken to improve readiness for the next major lethal pandemic event." The book was published just 2 months before the COVID-19 pandemic.  Find more about Dr. Hatfill at https://drstevenhatfill.com/ ABOUT DR. STEVE HATFILL Dr. Steven Hatfill is a specialist physician and a virologist with a military background and separate master's degrees in microbial genetics, radiation biochemistry, and experimental pathology. His medical fellowships include Oxford University, the NIH in Bethesda, and the NRC where he studied the Ebola Virus at the US Army Institute for Infectious Diseases at Fort Detrick. 「 SPONSORED BY 」 • BIRCH GOLD - Don't let your savings lose value. You can own physical gold and silver in a tax-sheltered retirement account, and Birch Gold will help you do it. Claim your free, no obligation info kit from Birch Gold at https://birchgold.com/drew • GENUCEL - Using a proprietary base formulated by a pharmacist, Genucel has created skincare that can dramatically improve the appearance of facial redness and under-eye puffiness. Genucel uses clinical levels of botanical extracts in their cruelty-free, natural, made-in-the-USA line of products. Get 10% off with promo code DREW at https://genucel.com/drew 「 MEDICAL NOTE 」 The CDC states that COVID-19 vaccines are safe, effective, and reduce your risk of severe illness. Hundreds of millions of people have received a COVID-19 vaccine, and serious adverse reactions are uncommon. Dr. Drew is a board-certified physician and Dr. Kelly Victory is a board-certified emergency specialist. Portions of this program will examine countervailing views on important medical issues. You should always consult your personal physician before making any decisions about your health.  「 ABOUT the SHOW 」 Ask Dr. Drew is produced by Kaleb Nation (https://kalebnation.com) and Susan Pinsky (https://twitter.com/firstladyoflove). This show is for entertainment and/or informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment. 「 WITH DR. KELLY VICTORY 」 Dr. Kelly Victory MD is a board-certified trauma and emergency specialist with over 30 years of clinical experience. She served as CMO for Whole Health Management, delivering on-site healthcare services for Fortune 500 companies. She holds a BS from Duke University and her MD from the University of North Carolina. Follow her at https://earlycovidcare.org and https://twitter.com/DrKellyVictory. 「 GEAR PROVIDED BY 」 • BLUE MICS - Find your best sound at https://drdrew.com/blue • ELGATO - See how Elgato's lights transformed Dr. Drew's set: https://drdrew.com/sponsors/elgato/ 「 ABOUT DR. DREW 」 For over 30 years, Dr. Drew has answered questions and offered guidance to millions through popular shows like Celebrity Rehab (VH1), Dr. Drew On Call (HLN), Teen Mom OG (MTV), and the iconic radio show Loveline. Now, Dr. Drew is opening his phone lines to the world by streaming LIVE from his home studio. Watch all of Dr. Drew's latest shows at https://drdrew.tv

On Daybreak Africa: World Health Organization authorities Wednesday declared Uganda free of the Ebolavirus after the East African nation went 42 days with zero infections but recorded a total of 55 deaths over a period of four months. Ethiopian federal forces report that their former rival Tigray forces have started handing over their weapons as part of the African Union led peace deal which is focused on ending the two-year civil war in the region.

In his weekly clinical update Dr. Griffin discusses Mpox (formerly monkeypox) in women: epidemiological features and clinical characteristics of mpox cases in Spain, April to November 2022, triage of patients with Ebola virus disease, SARS-CoV-2 serology and self-reported infection among adults, serological markers of SARS-CoV-2 infection; anti-nucleocapsid antibody positivity may not be the ideal marker of natural infection in vaccinated individuals, sensitivity of anti-SARS-CoV-2 nucleocapsid protein antibody for breakthrough infections during the epidemic of the Omicron variants, effect of wearing glasses on risk of infection with SARS-CoV-2 in the community, and data-driven identification of post-acute SARS-CoV-2 infection subphenotypes. Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Mpox in women: Epidemiological features and clinical characteristics of cases (Eurosurveillance)  Triage of patients with Ebola virus disease (The Lancet)  SARS-CoV-2 serology and self-reported infection among adults (CDC) Serological markers of SARS-CoV-2 infection (JID)  Sensitivity of anti-SARS-CoV-2 nucleocapsid protein antibody (Journal of infection) Effect of wearing glasses on risk of infection with SARS-CoV-2 in the community (JAMA) Paxlovid patient eligbiliity screening checklist (FDA) Data-driven identification of post-acute SARS-CoV-2 infection subphenotypes (Nature) Contribute to our MicrobeTV fundraiser at PWB Dr. Griffin's treatment guide (pdf) Letters read on TWiV 961 Timestamps by Jolene. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv

In his weekly clinical update Dr. Griffin discusses the four things to know about RSV, the burden of respiratory syncytial virus in healthy term-born infants in Europe, the diagnostic accuracy of rapid diagnostic tests for Ebola virus disease, evaluating the accuracy of self-collected swabs for the diagnosis of monkeypox, tecovirimat is effective against human monkeypox virus in vitro at nanomolar concentrations, acute and postacute sequelae associated with SARS-CoV-2 reinfection, clinical course of SARS-CoV-2 infection and recovery in lung transplant recipients, effectiveness of a third BNT162b2 mRNA COVID-19 vaccination during pregnancy, maternal antibody response and transplacental transfer following SARS-CoV-2 infection or vaccination in pregnancy, impact of community masking on COVID-19, Lifting Universal Masking in Schools – Covid-19 Incidence among Students and Staff, systematic review of the clinical effectiveness of Tixagevimab/Cilgavimab for prophylaxis of COVID-19 in immunocompromised patients, comparative effectiveness of sotrovimab and molnupiravir for prevention of severe COVID-19 outcomes in patients in the community, early adoption of anti–SARS-CoV-2 pharmacotherapies among us veterans with mild to moderate COVID-19, evaluation of viral and symptom rebound differences between Paxlovid and untreated COVID-19 participants, monoclonal antibodies for treatment of SARS-CoV-2 infection during pregnancy, twice daily oral zinc in the treatment of patients with COVID-19, cognitive deficits in long Covid-19, severe Neuro-COVID is associated with peripheral immune signatures, autoimmunity and neurodegeneration, and long-lasting symptoms after an acute COVID-19 infection and factors associated with their resolution. Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Four things to know about RSV (Gates Foundation) The burden of RSV in healthy term-born infants in Europe (The Lancet) Diagnostic accuracy of rapid tests for Ebola (CMI) Accuracy of self-collected swabs for diagnosis of Monkeypox (CID) Tecovirimat is effective against human monkeypox virus in vitro (Nature) Acute and postacute sequelae associated with SARS-CoV-2 reinfection (NatureMedicine) SARS-CoV-2 infection and recovery in lung transplant recipients (Transplant Infectious Diseases) Effectiveness of third COVID-19 vaccination during pregnancy (Nature Communications) Maternal antibody response and transplacental transfer following infection or vaccination (CID) Impact of community masking on COVID-19 (Science) Lifting universal masking in schools (NEJM) Bebtelovimab fact sheet for providers (FDA) Effectiveness of Tixagevimab/Cilgavimab for prophylaxis of COVID-19 (medRxiv) Effectiveness of Sotrovimab and Molnupiravir for prevention of severe COVID-19 outcomes (BMJ) Early adoption of Anti–SARS-CoV-2 pharmacotherapies among US veterans (JAMA) PAXLOVID patient eligibility screening checklist (FDA) Viral and symptom rebound differences between Paxlovid and untreated COVID-19 participants (medRxiv) Monoclonal antibodies for treatment of SARS-CoV-2 during pregnancy (Annals of Internal Medicine) Remdesivir fact sheet for providers (Veklury)  Twice daily oral zinc in the treatment of patients with COVID-19 (CID)  Cognitive deficits in long COVID-19 (NEJM) Severe Neuro-COVID associated with peripheral immune signatures, autoimmunity and neurodegeneration (Nature Communications) Long-lasting symptoms after an acute COVID-19 Infection (JAMA) Contribute to our MicrobeTV fundraiser at PWB Dr. Griffin's treatment guide (pdf) Letters read on TWiV 955 Timestamps by Jolene. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv

In his weekly clinical update Dr. Griffin discusses Influenza incidence and vaccine effectiveness during the southern hemisphere influenza season in Chile, Nirsevimab for prevention of RSV infection in healthy late-preterm and term infants, severe Monkeypox in hospitalized patients, reinfections with different SARS-CoV-2 Omicron subvariants, impact of community masking on COVID-19 in Bangladesh, unadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecoviruses, antibody responses to Omicron BA.4/BA.5 bivalent mRNA vaccine booster shot, immunogenicity of bivalent mRNA vaccine boosters, long-term gastrointestinal sequelae following COVID-19, evaluation of an automated text message–based program to reduce use of acute health care resources after hospital discharge, and how in adults with COVID-19, melatonin was assessed for effects on inflammatory markers, clinical signs and symptoms, and mortality. Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Influenza incidence and vaccine effectiveness (CDC) Nirsevimab for prevention of RSV (NEJM) Severe Monkeypox in hospitalized patients (CDC) Reinfections with different SARS-CoV-2 Omicron subvariants (CDC) Impact of community masking on COVID-19 (Science) Vaccine elicits protective immunity against sarbecoviruses (Science) Antibody responses to bivalent mRNA vaccine booster shot (Biorxiv) Immunogenicity of bivalent mRNA vaccine boosters (Biorxiv) Long-term gastrointestinal sequelae following COVID-19 (CGH) Remdesivir fact sheet for providers (Veklury)  Bebtelovimab fact sheet for providers (FDA) Evaluation of an automated text message–based program (JAMA) Melatonin assessed for effects on inflammatory markers in COVID patients (Heliyon) PAXLOVID patient eligibility screening checklist (FDA) Contribute to our MicrobeTV fundraiser at PWB Dr. Griffin's treatment guide (pdf) Letters read on TWiV 951 Timestamps by Jolene. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv

Zudem: Uganda startet in Kürze mit Impfungen gegen das Ebolavirus, das gerade grassiert. Und: Bakterien können Krebs auslösen. (00:40) Uganda will in den nächsten zwei Wochen mit klinischen Tests von experimentellen Impfstoffen gegen den Sudan-Stamm des Ebolavirus beginnen, anderthalb Monate nach Bekanntwerden des Ausbruchs. Drei Impfstoff-Kandidaten stehen bereit. Das rasche Tempo ist das Resultat einer langjährigen Vorbereitung. (13:30) Viren, UV-Strahlen und Tabakrauch lösen Krebs aus, das ist bekannt. Neu wird klar: Auch Bakterien können unser Erbgut schädigen, und spielen eine Rolle bei der Entstehung von Darmkrebs. (19:45) Mit Satellitenschüsseln und Mikrofonen kann man vom Boden aus den Vögeln zuhören, wenn sie auf ihren langen Migrationswegen über unsere Köpfe hinwegfliegen. Besuch bei einem Hobby-Ornithologen in Basel.

O continente africano sofre com o Ebolavirus desde 1976. Entenda o motivo para esse vírus ser tão letal e difícil de controlar. https://www.cdc.gov/vhf/ebola/index.html

This week we take a look at the current Ebola Virus outbreak occurring in Uganda. While currently still relatively small in size, this outbreak has been identified as involving the Sudan strain of Ebola, which currently does not have an approved vaccine nor pharmaceuticals to treat. Thanks for listening, your support is greatly appreciated! Follow the show! https://www.instagram.com/destination.disaster/https://twitter.com/DestDisasterSources: https://en.wikipedia.org/wiki/Ebolahttps://www.ncbi.nlm.nih.gov/books/NBK560579/https://www.sciencedirect.com/topics/agricultural-and-biological-sciences/sudan-ebola-virushttps://ehs.stonybrook.edu/programs/laboratory-safety/biological-safety/biosafety-levelshttps://emergency.cdc.gov/agent/agentlist-category.aspIntro/Out Music: Cody Martin - Leviathanhttps://app.soundstripe.com/songs/14667 Hosted on Acast. See acast.com/privacy for more information.

Uganda is experiencing its first outbreak in a decade of the deadly Ebola disease caused by Sudan virus, health authorities announced in September. More than 40 cases and at least 29 deaths have been reported, including four health workers. Nine of these deaths are from confirmed cases. While there are vaccines against the more common Zaire strain, there are no licensed vaccines or therapeutics for Sudan ebolavirus.In this episode of Africa Science Focus, we find out more about the current outbreak in Uganda from the World Health Organizations's Patrick Otim. Dimie Ogoina, president of the Nigerian Infectious Diseases Society, tells us what the continent must do to curb the spread of the virus and prevent future outbreaks.This piece was produced by SciDev.Net's Sub-Saharan Africa English desk.Do you have any comments, questions or feedback about our podcast episodes? Let us know at podcast@scidev.net

Gegen den sogenannten Sudan-Typ des Ebola-Virus, der in Uganda kursiert, gibt es bislang keinen Impfstoff. Allerdings könnten Quarantäne-Maßnahmen helfen, die Ausbreitung einzudämmen, sagt Virologe Stephan Becker.Pyritz, LennartDirekter Link zur Audiodatei

Accessibility is one of the greatest challenges facing the healthcare industry in Africa, whether in preventive care, curative care or innovative medicines- but is also its greatest opportunity. Over the past three years, Walter Mibei has been at the forefront of leading efforts in the COVID-19 and Ebola Virus pandemic response in sub-Saharan Africa. He has 12 years of experience since qualifying as a doctor, working with companies such as Johnson & Johnson and Novo Nordisk. He is currently taking a mid-career break which he is spending as a Sloan Fellow at The Stanford Graduate School of Business. In this episode, we look at his transitions over the course of his career and break down the opportunities available for actionable solutions in accessible healthcare to better prepare Africa for the next pandemic. Find out more about Walter through his LinkedIn: https://www.linkedin.com/in/walter-mibei/ Support our podcast further by subscribing to our Patreon Page here: https://www.patreon.com/boardroombanter?fan_landing=true

Officials say a person recently admitted to a hospital in Mubende after presenting Ebola symptoms died four days later.

We are on the verge of the Supreme Court's overturning of Roe v. Wade, the 1973 decision that legalized abortion throughout the United States.  With this decision, other landmark rulings including those that legalized access to contraception, gender-affirming care, and same-sex marriage may also be threatened.  How did we get here? Of course, this is a rhetorical question, as we have experienced the federal government and state-based legislatures, coupled with legal campaigns, chip away at Roe for the past 49 years.  I have been interested in understanding which stories, storytellers, (former president Trump comes to mind), and cultural forces are drowning out the narratives from the 6 in 10 (61%) Americans who believe that abortion should be legal in all or most cases.An intriguing exploration is Mid-Century, a horror film starring Chelsea Gilligan and edited by Stephanie Filo.  Seemingly about a husband and wife's weekend in a mid-century modern vacation rental turns deadly, the story brings to life the narratives that helped to move the U.S. to this political moment.  Written during the Trump administration, the film shows the power and cruel consequences of former president Trump's narrative of an imagined time when America was at its greatest: The 1950s, a pre-civil, gender, and LGBTQ+ rights era, amongst most human rights.I talked with Chelsea Gilligan, who plays Dr. Alice Dodgeson, the lead role, and Stephanie Filo.  We talked about everything from their work on the film and the entertainment industry to their life journeys and love of community and cooking.Stephanie Filo, ACE is a two-time Emmy and Peabody Award-winning TV/Film Editor and activist based in Los Angeles, CA and Sierra Leone, West Africa. She serves on the board for Girls Empowerment Sierra Leone, a social impact and feminist-based organization for Sierra Leonean girls aged 11-16. She is one of the co-founders of End Ebola Now, an organization created in 2014 to spread accurate information and awareness about the Ebola Virus and its impact through artistic community activism.Chelsea Gilligan made her series regular debut on The CW's "Star-Crossed" where Gilligan portrayed "Teri," a tough as nails high school student, who also happens to be an alien. Her past credits include roles on shows like "How I Met Your Mother," Victorious" and "Big Time Rush."

Kaleb describes the horrifying symptoms that lead to a bloody death, thanks to the Ebola Virus. 

McGill Business Professor Henry Mintzberg is the author of 20 books on management, creator of two revolutionary international management programs, and the recipient of a mountain of accolades and honors for his thought leadership in the business world. Mintzberg minces no words in his pointed criticism of current approaches to management training and the behavior of those in management and leadership positions. In this interview, Professor Mintzberg comments on the value of an MBA in providing management skills:“Anybody who comes out of a business school should have a stamp on his or her forehead—like a skull and crossbones—that says Warning! Not Prepared to Manage.”He explains how managers get distorted during traditional business education. Management is a practice where art, craft and science intersect. Because the art and craft cannot be taught in a business school setting, the “science” has become the focus of graduate business education. Thus, MBAs emerge with skills in marketing, finance, and accounting but lack the very “essence” of management—the art and the craft. He explains why “remote control managers” are dangerous. These are people who manage by the numbers, with monitoring and measuring substituting for actually knowing what's going on in the business. This lack of understanding has implications for the success and capacity of the organization and disconnection from the ground floor of the organization impairs innovation.Professor Mintzberg says healthcare should not be run like a business. In fact, he states, “most businesses should not be run like a business.” He makes it clear that this is especially true in professions and in services like medicine and healthcare. Healthcare is not a business, it's a calling.Professor Mintzberg points to the pros and cons of various groups such as physicians, nurses, MBAs, accountants and others who seek to lead healthcare institutions. He believes managers must know and understand the services being offered, be unequivocally collaborative, and humble enough to learn. Physicians who succeed in business are those who collaborate and build relationships. Mintzberg, an internationally recognized iconoclast, believes jail is the most appropriate destination for board members who approve super-sized CEO salaries and for the executives who accept them. He states that huge salaries are dysfunctional nonsense and the opposite of leadership that leads to “a kind of narcissism.” When asked about incentives for physicians, Professor Mintzberg exudes enthusiasm. “Yes! A patient whose life has been saved and who is appreciative is a terrific incentive!” But treating physicians like caged pigeons and giving them little rewards for their work is just silliness. Professor Mintzberg talks about the structure, purpose, and successes of the International Masters for Health Leadership program which he co-founded. And he shares a high level overview of his important work focused on the need to rebalance society. An imbalance in three sectors, the public, private and what he calls the plural sector, are at the root of many of society's most harmful and dysfunctional patterns. This is so relevant to healthcare, which is being destroyed by inroads by the profit-driven private sector. In this episode:•Why Professor Mintzberg's quadruple bypass cost $2.50 •How beaver artists find gallery space•The Supreme Court legalized bribery in the Citizens United decision•Mintzberg's Masters Program, Ebola Virus, and Doctors Without Borders•Dulcie and the Infinite List of Positive CharacteristicsMeet Henry MintzbergHenry Mintzberg, PhD, is a professor in the Desautels Faculty of Management at McGill University in Montreal. He sits in the Cleghorn Chair of Management Studies and has had extensive visiting professorships at INSEAD in France and the London Business School in England.As an internationally renowned author and educator, he has received an avalanche of honorary degrees, awards, and recognition for his iconoclastic thought leadership in the realm of business. He has authored 20 books and nearly 200 articles, and speaks frequently on podcasts and regularly publishes a TWOG (Tweet to Blog) which he calls “provocative fun.”He co-founded and remains active in the International Masters Program for Managers and the International Masters for Health Leadership as well as the venture CoachingOurselves.com. These are all novel, successful, and highly regarded initiatives for managers to learn together from their own experience, with CoachingOurselves.com occurring in the participants' own workplace.Professor Mintzberg is also an outdoorsman and collector of peculiar beaver sculptures, which he enthusiastically discusses in this episode.Resources:•Website: https://mintzberg.org/•Newest Book: https://mintzberg.org/books/bedtime-stories-for-managers•Website: https://rebalancingsociety.org/•Twitter: @mintzberg141 •International Masters Program for Managers: https://impm.org/•International Masters for Health Leadership: https://www.mcgill.ca/desautels/programs/international-masters-health-leadership•SIGN UP FOR OUR NEWSLETTER: https://bit.ly/LicensedToLeadSignup

Elke, Adam, and Gabor join TWiV to discuss their work on Lloviu virus, a filovirus, including recovery of infectious virus from a DNA copy of the genome and from Schreiber's bats in Hungary. Hosts: Vincent Racaniello, Rich Condit, Kathy Spindler, and Brianne Barker Guests: Elke Muhlberger, Adam Hume, and Gabor Kemenesi Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Elke on TWiV 200 and Threading the NEIDL Infectious Lloviu virus from bats in Hungary (Nat Commun) Infectious Lloviu virus from DNA (PloS Path) Letters read on TWiV 891 Timestamps by Jolene. Thanks! Weekly Picks Brianne – APod Stars and Globules in the Running Chicken Nebula Kathy – BioRender Poster Builder Rich – The Sins of Our Fathers: An Expanse Novella (The Expanse) by James S. A. Corey Vincent – Baumgartner Restoration Listener Pick J – Time, Einstein, and the coolest stuff in the Universe Intro music is by Ronald Jenkees Send your virology questions and comments to twiv@microbe.tv

Episode 33With new Ebola outbreaks in Guinea and the Democratic Republic of Congo, Africa Science Focus investigates whether the Ebola virus can be sexually transmitted.  It is understood that the women who were the first reported patients in both countries were married to survivors of previous Ebola outbreaks. Scientists say this possible transmission link needs careful attention, without further stigmatising survivors, who face ongoing health and social challenges.   We hear from the World Health Organization's Margaret Harris, founder of the Sierra Leone Association of Ebola Survivors Yusuf Kabba, and Merawi Aragaw from the Africa CDC. And, researcher Jia Kangbai tells us about his new study, which will investigate what role sex could play in transmission of the Ebola virus. Is there something you want to know about science in Africa? Send us your questions from anywhere in the world and we'll find an expert to answer them — text or voice message via WhatsApp to +254799042513.   Africa Science Focus, with Selly Amutabi. Do you have any comments, questions or feedback about our podcast episodes? Let us know at podcast@scidev.net

When she was just 8 years old, Dr. Saskia Popescu's step-mother handed her a copy of The Hot Zone: The Terrifying True Story of the Origins of the Ebola Virus. That simple act kicked off a string of events that would positively impact thousands of lives. At TIPS, we believe that one person can make a difference and everyone should try. Sometimes that person becomes a renowned infectious diseases epidemiologist and infection preventionist who specializes in biopreparedness, biosecurity, and pandemic response, and guides hospitals and businesses safely through a pandemic, like Dr. Popescu. Other times they make a difference simply by opening the mind of a child to the great possibilities of the world. Both matter.   What's it really like on the front-lines of healthcare? Dr. Popescu was on the front-lines as an infection preventionist long before the COVID-19 pandemic. And she, like many in the healthcare industry, was already running beyond capacity. Infection Prevention efforts are notoriously under-funded and under-prioritized by hospitals. Dr. Popescu tells us that she's “never seen a fully staffed infection prevention department.” Similarly, doctors and nurses were already struggling with an epidemic of clinician burnout. To truly understand the context of what it's like out there, we must remember that everything our front-line workers are dealing with now is in addition to that existing burden. Dr. Popescu tells us how this feels, how she and her colleagues are dealing with it, and how their hospitals can help. The need, Dr. Popescu tells us, goes way beyond providing access to personal protective equipment (PPE). Some hospitals are smartly supporting their staff with child care, mental health support, meal delivery, and other non-work-related services that go a long way towards helping their teams cope with the pressure.   The challenges of scientific communication Dr. Popescu has been recognized for her communication efforts around the pandemic. In her view, the U.S. has struggled to translate nuanced CDC guidance into actual application, especially when working with people unfamiliar with the science. This is particularly true when dealing with the public. Dr. Popescu shares a few lessons learned through this experience that can and should be improved upon going forward.   We did a poor job of informing the public that guidance was likely to change. We're dealing with a novel virus, and our experts are learning on the fly in unfavorable conditions. It makes sense that things would change, but it also makes sense that people would react poorly if they were not prepared for that change. The statistics and measures we are focused on may not be the most effective for helping the public understand what's going on. We focus on positivity rates, death rates, and ICU bed counts, but little on what's happening outside of the ICU and provide no breakdowns in terms of disease severity.   We also get into the need to account for politics in future communications efforts and much more. Surely, the communications lessons of the COVID-19 pandemic will be dissected for years to come.   Historical Lessons Dr. Popescu also takes us through comparative lessons from past pandemics. The lessons we're learning today can and should be combined with those past experiences to make our next response that much more effective. We can even look to the experiences of dominant nation-states of the past like Rome. The fall of Rome is a complex topic with many factors, but infectious disease certainly contributed to its demise. Dr. Popescu tells us that “disease has a big impact on critical infrastructure and can be very destabilizing”. That is evident today, and we'd be wise not to ignore the challenges that followed these events of the past.   The Path Forward The bulk of our efforts today should be focused on saving lives, supporting healthcare workers, distributing vaccines, and ending this pandemic. However, it's never too early to begin extracting our lessons and planning for the future. Coming out of this, Dr. Popescu says, “I hope that from the top-down, from the bottom-up, we all are much more cognizant of global health security.” That means looking not just at infection control, but antimicrobial resistance testing, lab capacity, healthcare worker capacity, and more. And this can't be a fleeting interest where we throw a bunch of money at the problem and think we're handling it. Instead, we need a sustained, methodical approach with clear metrics for success.   This is a wonderfully thoughtful and thorough discussion on one of the most important topics of our time. I hope you get as much out of it as we did.   Dr. Saskia Popescu Saskia Popescu is an infectious disease epidemiologist and Senior Infection Preventionist in Phoenix, Arizona. She holds academic appointments at the University of Arizona and George Mason University, where she lectures on biopreparedness, and pandemic and outbreak response. Since the start of the COVID-19 pandemic, she's worked to prepare for and mitigate the spread of the disease. She has been recognized for her communication efforts around the pandemic, as well as her work on the front lines. Dr. Popescu holds a PhD in Biodefense from George Mason University, a Masters in Public Health with a focus on infectious diseases, and a Masters of Arts in International Security Studies, from the University of Arizona. Dr. Popescu is an Alumni Fellow of the Emerging Leaders in Biosecurity Initiative (ELBI) at the Johns Hopkins Bloomberg School of Public Health, Center for Health Security. She currently serves as a member of the Federation of American Scientists (FAS) Coronavirus Taskforce and is a member of the Committee on Data Needs to Monitor Evolution of SARS-CoV-2 within the Health and Medicine Division of the National Academies of Sciences, Engineering, and Medicine (NASEM).  Follow Dr. Popescu on Twitter (@SaskiaPopescu) Read Dr. Popescu's bio on the George Mason university biodefense program website   Links and Resources ‘Long-haul' covid-19 complications are real. I faced similar problems after surviving Ebola. by DR. Craig Spencer This is the NHS video Dr. Popescu mentioned: https://twitter.com/SaskiaPopescu/status/1329070401834475522

Here are the links for everything discussed in Episode 45, I'm also including times here so feel free to skip ahead to the topics that interest you. (1:22) Approval of Veklury to treat COVID19 (8:38) Inmazeb approved for Ebola virus CDC updates on COVID-19 & influenza reportingConnect with The Rx Daily Dose:Twitter      Instagram      YouTube      Linkedin       WebsiteEmail: therxdailydose@gmail.comConnect with Ian Parnigoni PharmD. on social media:Twitter       Instagram       Linkedin  ★ Support this podcast on Patreon ★

The Quaranteens explore the Ebola Virus and lessons learned from the West African Ebola Virus Epidemic

Experiencing the first major Zaire Ebola outbreak in 1976 in Northwest Congo. With special guest Dr. Tom Cairns, the first non-African Ebola virus survivor.

I am back at it with my thoughts on how the media covers disease outbreaks. Sources Understanding H1N1 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3074714/ Coverage of Ebola https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4300452/ Media effects on students https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3320361/ Bullies attack Asian American teen https://www.cbsnews.com/news/coronavirus-bullies-attack-asian-teen-los-angeles-accusing-him-of-having-coronavirus/?fbclid=IwAR0PsZC8cljItu53MBpJo7JxGGgBgVF8kCM6yhmq5UiY1WqiBscPzHzPLcM Media Messages https://wwwnc.cdc.gov/eid/article/23/1/16-0589_article SARS facts https://www.cdc.gov/sars/about/fs-sars.html SARS Timeline https://www.cdc.gov/about/history/sars/timeline.htm Which is the real pandemic https://www.euronews.com/2020/02/05/which-is-the-real-pandemic-coronavirus-or-the-hysteria-that-follows-euronews-reality-check Social media infodemic https://www.technologyreview.com/s/615184/the-coronavirus-is-the-first-true-social-media-infodemic/ Understanding Ebola https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5022139/ SARS killed hundreds https://www.latimes.com/california/story/2020-02-18/sars-coronavirus-china-epidemic The H1N1 pandemic https://bmcpublichealth.biomedcentral.com/articles/10.1186/1471-2458-13-1116 Outbreaks breed hysteria https://www.theatlantic.com/health/archive/2014/10/why-outbreaks-breed-hysteria/381898/ COVID-19 advice https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public/myth-busters COVID-2019 Situation Reports https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/ Ebola Virus https://www.who.int/health-topics/ebola/#tab=tab_1 SARS Cases https://www.who.int/csr/sars/country/table2004_04_21/en/ Role of media https://www.longdom.org/open-access/role-of-media-in-portraying-ebola-in-and-outside-africa-2329-891X-1000152.pdf SARS Lessons https://niemanreports.org/articles/lessons-from-sars-coverage/

Episode 34 starts with the standard Introduction and Segment Summary where Tucker covers the latest news with his Development company as well as what the topics will be for each segment.   He then goes into our special announcement segment about our Show Sponsor, Iron Bridge Lending.  In the "Deal of the Week" segment Tucker goes into detail about a Probate Wholesale Deal that went bad and teaches you how to avoid this.  In the place of the "Main Topic" segment, Tucker introduces our newest segment, "Common Sense Ain't So Common" where he and our "Super Realtor" Chris, discuss Realtors and one realtor in particular that we worked with on a deal.  He then goes into "Direct Mails Greatest Hits" and plays a voicemail that was submitted by a listener and makes comments on it.  Tucker then transitions into the "Golden Nugget" where he discusses Wholesaling to Builders and how to get bigger wholesale fees.  In the "No BS Zone" segment, he goes off topic and comments on the Ebola Virus scare thats currently all over the news.  Tucker then ends the Episode with a great Success Quote from anonymous source that he really liked.  We hope you enjoy this episode and please leave us comments and reviews!

Episode #2: Tune in this week for the special #Halloween episode!!  Hear the story of how Chuck and Josh first met back in the 90s and other tales of contests, costumes and so much more!  #ChuckShutePodcast #Podcast0:00 - Intro / Story of Chuck & Josh7:42 - The A-Team 17:36 - The Golden Girls21:24 - Dumb & Dumber24:55 - Weekend at Bernie's28:11 - Teen Wolf & The Ambiguously Gay Duo30:51 - Weekend at Bin Laden's: Team Seal 637:49 - E.T. The Extra Terrestrial & Ace Ventura39:27 - Marty McFly & Grumpy Cat41:02 - The Ebola Virus 43:41 -  Ferris Bueller's Day Off & The Goonies47:57 - Tom Petty, Chris Cornell & Carrie Fisher49:05 - Uncle Rico & Magnum P.I. Youtube Linkhttps://youtu.be/zpdpktVApb4

A strain that emerged during the latest epidemic is able to enter human cells more easily—which means it's more infectious, too. Christopher Intagliata reports. 

Dr. Ting Lee from the center for disease Control calls in to give us an Ebola update. A Pavement Pounder calls with words of inspiration. And do you let your friends expire?? Crab cake crack face!!!! Learn more about your ad choices. Visit megaphone.fm/adchoices

A specialist from the Center for Disease Control calls in to discuss the dangers of the Ebola Virus in North America. When we die do we go to a "Better Place"? The sounds of Canadian rock band SAGA. Hickory stick a Bic (pen)!!! Learn more about your ad choices. Visit megaphone.fm/adchoices

The post I Doubt It #043 – “Facebook 911, Mild Dumbass Richard Dawkins, Public Prayer Discount, and Ebola Virus Cures” appeared first on I Doubt It Podcast.